Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2006 3
2007 4
2008 3
2009 3
2010 3
2011 1
2013 6
2014 5
2015 5
2016 9
2017 6
2018 7
2019 12
2020 14
2021 14
2022 18
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results.
Anagnostou V, Ho C, Nicholas G, Juergens RA, Sacher A, Fung AS, Wheatley-Price P, Laurie SA, Levy B, Brahmer JR, Balan A, Niknafs N, Avrutin E, Zhu L, Sausen M, Bradbury PA, O'Donnell-Tormey J, Gaudreau PO, Ding K, Dancey J. Anagnostou V, et al. Among authors: ho c. Nat Med. 2023 Oct;29(10):2559-2569. doi: 10.1038/s41591-023-02598-9. Epub 2023 Oct 9. Nat Med. 2023. PMID: 37814061 Free PMC article. Clinical Trial.
Lung Cancer in Canada.
Ho C, Lefresne S, Liberman M, McGuire A, Palma D, Pender A, Snow S, Tremblay A, Myers R. Ho C, et al. J Thorac Oncol. 2019 Jul;14(7):1128-1133. doi: 10.1016/j.jtho.2019.02.012. J Thorac Oncol. 2019. PMID: 31235034 Free article. No abstract available.
Hyper-Sensitive? Targeted Therapy With a Primed Immune System.
Rittberg R, Abraham N, Laskin J, Ho C. Rittberg R, et al. Among authors: ho c. J Thorac Oncol. 2022 Jun;17(6):734-736. doi: 10.1016/j.jtho.2022.03.003. J Thorac Oncol. 2022. PMID: 35623671 Free article. No abstract available.
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
Lee VH, Adham M, Ben Kridis W, Bossi P, Chen MY, Chitapanarux I, Gregoire V, Hao SP, Ho C, Ho GF, Kannarunimit D, Kwong DL, Lam KO, Lam WKJ, Le QT, Lee AW, Lee NY, Leung TW, Licitra L, Lim DW, Lin JC, Loh KS, Lou PJ, Machiels JP, Mai HQ, Mesía R, Ng WT, Ngan RK, Tay JK, Tsang RK, Tong CC, Wang HM, Wee JT. Lee VH, et al. Among authors: ho c. Lancet Oncol. 2022 Dec;23(12):e544-e551. doi: 10.1016/S1470-2045(22)00505-8. Lancet Oncol. 2022. PMID: 36455583 Free PMC article. Review.
Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.
Boucher A, Ezzat S, Hotte S, Rachinsky I, Rajaraman M, Ruether D, Wiseman SM, Brierley J, Ho C, Krzyzanowska M, Lamond N, Massicotte MH, Joseph S, Herscovitch K, Sikora L, Winquist E. Boucher A, et al. Among authors: ho c. Oral Oncol. 2021 Oct;121:105477. doi: 10.1016/j.oraloncology.2021.105477. Epub 2021 Aug 10. Oral Oncol. 2021. PMID: 34388408 Free article. Review.
Defining a Core Data Set for the Economic Evaluation of Precision Oncology.
Pollard S, Weymann D, Chan B, Ehman M, Wordsworth S, Buchanan J, Hanna TP, Ho C, Lim HJ, Lorgelly PK, Raymakers AJN, McCabe C, Regier DA. Pollard S, et al. Among authors: ho c. Value Health. 2022 Aug;25(8):1371-1380. doi: 10.1016/j.jval.2022.01.005. Epub 2022 Feb 23. Value Health. 2022. PMID: 35216902 Free article. Review.
116 results